Efficacy and safety of dupilumab in Japanese adults with moderate‐to‐severe atopic dermatitis: a subanalysis of three clinical trials-Reference-Cited by-同舟云学术

Efficacy and safety of dupilumab in Japanese adults with moderate‐to‐severe atopic dermatitis: a subanalysis of three clinical trials

Published:2019-11-28 Issue:1 Volume:183 Page:39-51
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Katoh N.¹^ORCID,Kataoka Y.²^ORCID,Saeki H.³^ORCID,Hide M.⁴^ORCID,Kabashima K.⁵^ORCID,Etoh T.⁶,Igarashi A.⁷,Imafuku S.⁸,Kawashima M.⁹,Ohtsuki M.¹⁰,Fujita H.¹¹,Arima K.¹¹^ORCID,Takagi H.¹¹,Chen Z.¹²,Shumel B.¹²,Ardeleanu M.¹²

Affiliation:

1. Department of Dermatology Kyoto Prefectural University of Medicine Graduate School of Medical Science Kyoto Japan

2. Department of Dermatology Osaka Habikino Medical Center Osaka Japan

3. Department of Dermatology Nippon Medical School Tokyo Japan

4. Department of Dermatology Hiroshima University Hiroshima Japan

5. Department of Dermatology Kyoto University Graduate School of Medicine Kyoto Japan

6. Department of Dermatology Tokyo Teishin Postal Services Agency Hospital Tokyo Japan

7. Department of Dermatology NTT Medical Center Tokyo Tokyo Japan

8. Department of Dermatology Fukuoka University Fukuoka Japan

9. Department of Dermatology Tokyo Women's Medical University School of Medicine Tokyo Japan

10. Department of Dermatology Jichi Medical University Tochigi Japan

11. Sanofi K.K. Tokyo Japan